logo-loader
viewMogrify

Mogrify developing 'mind-blowing science' in the cell therapy space

Mogrify CEO Dr Darrin Disley sat down with Proactive’s Christine Corrado at BIO CEO in New York.

The UK-based company has developed a direct cellular conversion platform technology that, according too the company, makes it possible to routinely transform any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state. Disley is also a former board member of the UK-based BioIndustry Association (BIA), a UK-based trade association for life sciences.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Ideanomics’ massive EV expo center in Qingdao, China is...

Ideanomics (NASDAQ: IDEX) CEO Alf Poor joined Steve Darling from Proactive with the news the company has finally opened the largest auto trading market in Qingdao at MEG's Qingdao EV hub. Poor discusses why they decided to build this superstore and also why this location is perfect to service...

28 minutes ago

2 min read